SS
OCUL icon

Sunbelt Securities’s Ocular Therapeutix OCUL Stock Holding History

Sunbelt Securities’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127 Buy
+15
New +$143 ﹤0.01% 2602

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sunbelt Securities's OCUL Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 15 shares worth $127. The stake represents ﹤0.01% of the portfolio and ranks #2602 among its holdings.

271 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Sunbelt Securities held 15 shares of Ocular Therapeutix worth $127 as of Q1 2026.
  • Ocular Therapeutix was a new Sunbelt Securities position in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2602 holding.
  • 271 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.